ly 303511 has been researched along with dichlororibofuranosylbenzimidazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Kholy, W; Fox, JM; Light, PE; Lin, JH; Macdonald, PE; Tsushima, RG; Wang, J; Wang, Q; Wheeler, MB | 1 |
1 other study(ies) available for ly 303511 and dichlororibofuranosylbenzimidazole
Article | Year |
---|---|
The phosphatidylinositol 3-kinase inhibitor LY294002 potently blocks K(V) currents via a direct mechanism.
Topics: Androstadienes; Animals; Cell Line; Cells, Cultured; Chromones; Dichlororibofuranosylbenzimidazole; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Morpholines; Patch-Clamp Techniques; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Potassium Channels, Voltage-Gated; Rats; Signal Transduction; Transfection; Wortmannin | 2003 |